Results 31 to 40 of about 5,761 (217)

Improved lung function using a therapeutic educational multidisciplinary program in a pediatric cystic fibrosis clinic [PDF]

, 2013
Background: Pulmonary disease remains the most common cause of morbidity and mortality in cystic fibrosis. The clearing of mucus by chest physiotherapy is a major keystone of treatment.
Ballabeni, Pierluigi, Durussel, Claudine, Hafen, Gaudenz Martin, Kernen, Yann   +3 more
core   +1 more source

Methotrexate does not affect lung function in children with juvenile idiopathic arthritis

, 2023
Pediatric Pulmonology, Volume 58, Issue 12, Page 3630-3636, December 2023.
Thomas Perrin, Laurianne Coutier, Julien Ranchoup, Anas Rifard, Mathilde Eymery, Camille Ohlmann, Marie‐Christine Werck‐Gallois, Audrey Laurent, Marine Desjonquères, Agnès Duquesne, Alexandre Belot, Philippe Reix   +11 more
wiley   +1 more source

TLR3 promotes MMP-9 production in primary human airway epithelial cells through Wnt/β-catenin signaling

Respiratory Research, 2017
Background Airway epithelial cells (AEC) act as the first line of defence in case of lung infections. They constitute a physical barrier against pathogens and they participate in the initiation of the immune response.
P.-J. Royer, K. Henrio, M. Pain, J. Loy, A. Roux, A. Tissot, P. Lacoste, C. Pison, S. Brouard, A. Magnan, the COLT consortium   +10 more
doaj   +1 more source

The Prognosis of ART Is Not Altered in Cystic Fibrosis Women: A Case-Report Study

Frontiers in Endocrinology, 2022
Research QuestionUnlike in men, a very limited number of studies were focused on the specificity of ART management of cystic fibrosis (CF) in women. The purpose of this study was to determine the causes of infertility in patients, the appropriate ART ...
Inès Braham, Adeline Morisot, Samir Boukaïdi, Marie Perceval, Isabelle Durieu, Christine Rousset-Jablonski, Sylvie Hieronimus, Sylvie Leroy, Nicolas Chevalier, Nicolas Chevalier   +9 more
doaj   +1 more source

Efficacy of Ruxolitinib in Severe Pediatric Intra-Alveolar Hemorrhages Unrelated to COPA Mutations. [PDF]

Pediatr Pulmonol
Pediatric Pulmonology, Volume 60, Issue 1, January 2025.
Le A, Perrin T, Drummond D, Reix P, Bader-Meunier B, Rice GI, Duffy D, Frémond ML, Hadchouel A.   +8 more
europepmc   +2 more sources

Exposition domiciliaire aux moisissures : quel impact sur le statut aspergillaire du patient atteint de mucoviscidose ?

, 2015
National ...
Belaz, S., Chevrier, S., Deneuville, E., Frain, S., Gangneux, Jean-Pierre, Pricope, D., Roussey, M.   +6 more
core   +4 more sources

Neonatal low respiratory tract chlamydia trachomatis infection: Diagnostic and treatment management

Respiratory Medicine Case Reports, 2019
Maternal infection during pregnancy by Chlamydia trachomatis (Chlamydia t.) can result in neonatal interstitial lung disease. It remains difficult for physicians to establish this diagnosis and to select the best treatment, as there is no recommendation.
M. Jouglet, I. Wuillaume, C. Buchs, P. Reix, C. Schweitzer, L. Coutier   +5 more
doaj   +1 more source

The gut-lung axis in the CFTR modulator era

Frontiers in Cellular and Infection Microbiology, 2023
The advent of CFTR modulators represents a turning point in the history of cystic fibrosis (CF) management, changing profoundly the disease’s clinical course by improving mucosal hydration.
Florian Lussac-Sorton, Florian Lussac-Sorton, Éléna Charpentier, Éléna Charpentier, Sébastien Imbert, Sébastien Imbert, Sébastien Imbert, Maxime Lefranc, Stéphanie Bui, Stéphanie Bui, Stéphanie Bui, Michael Fayon, Michael Fayon, Michael Fayon, Patrick Berger, Patrick Berger, Patrick Berger, Raphaël Enaud, Raphaël Enaud, Raphaël Enaud, Laurence Delhaes, Laurence Delhaes, Laurence Delhaes   +22 more
doaj   +1 more source

Une politique de santé "a priori". Le dépistage néonatal de la mucoviscidose en Bretagne

, 2004
Le dépistage néonatal de la mucoviscidose (DNM), qui fait l'objet d'un débat, au plan international, sur son opportunité, a été décidé officiellement en 2002 en France.
Vailly, Joëlle
core   +2 more sources

Prevalência da mutação ΔF508 no gene cystic fibrosis transmembrane conductance regulator em pacientes com fibrose cística em um centro de referência no Brasil

Jornal de Pediatria, 2012
OBJETIVO: Verificar a presença da mutação ΔF508 no gene cystic fibrosis transmembrane conductance regulator na população de pacientes com fibrose cística, diagnosticados pelo teste de sódio e cloro no suor, em acompanhamento no Ambulatório de Pneumologia
Andréia Marisa Bieger, Fernando Augusto de Lima Marson, Carmen Sílvia Bertuzzo   +2 more
doaj   +1 more source